Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.

Takayuki UenoShigehisa KitanoNorikazu MasudaDaiki IkarashiMakiko YamashitaTomohiro ChibaTakayuki KadoyaHiroko BandoTakashi YamanakaShoichiro OhtaniShigenori NagaiTakahiro NakayamaMasato TakahashiShigehira SajiKenjiro AogiRavi VelagaKosuke KawaguchiSatoshi MoritaHironori HagaShinji OhnoMasakazu Toi

Published in: BMC medicine (2022)

UMIN000023162.

Keyphrases

neoadjuvant chemotherapy
dna repair
dna damage
locally advanced
lymph node
sentinel lymph node
stem cells
replacement therapy
rectal cancer
squamous cell carcinoma
oxidative stress
early stage
smoking cessation